Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis

BACKGROUND: Scleroderma is a systemic autoimmune disease characterized mainly by skin manifestations and involvement of various visceral organs, especially the lungs. Lung involvement is the leading cause of mortality in patients with scleroderma. There are data to suggest that cyclophosphamide (CYC...

Descripción completa

Detalles Bibliográficos
Autores principales: Shenoy, Padmanabha D., Bavaliya, Manish, Sashidharan, Sujith, Nalianda, Kaveri, Sreenath, Sreelakshmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890256/
https://www.ncbi.nlm.nih.gov/pubmed/27255492
http://dx.doi.org/10.1186/s13075-016-1015-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890256/
https://www.ncbi.nlm.nih.gov/pubmed/27255492
http://dx.doi.org/10.1186/s13075-016-1015-0

Ejemplares similares